Gene regulation in activated microglia by adenosine A₃ receptor agonists: a transcriptomics study

Area of Science:

• Neuroscience
• Immunology
• Pharmacology

Background:

• Neurodegenerative diseases like Alzheimer and Parkinson involve microglial activation.
• A₃ adenosine receptor (A₃R) agonists are investigated for potential neuroprotection by modulating microglial phenotypes.

Purpose of the Study:

• To investigate the effect of a selective A₃R agonist (2-Cl-IB-MECA) on gene expression in activated microglia.
• To determine if A₃R activation promotes a neuroprotective microglial phenotype (M2).

Main Methods:

• RNA sequencing of microglia activated by lipopolysaccharide/interferon-γ and treated with 2-Cl-IB-MECA.
• Gene ontology enrichment analysis to identify regulated cellular processes.
• Protein-protein interaction analysis to identify key transcription factors.

Main Results:

• More genes were negatively regulated than positively regulated by 2-Cl-IB-MECA.
• Gene ontology analysis revealed regulation of immune-related and other cellular processes.
• Smad3 and Sp1 were identified as transcription factors regulated by A₃R activation.
• The A₃R agonist did not favor the expression of genes associated with M2 neuroprotective microglia.

Conclusions:

• A₃R activation in microglia leads to broad gene expression changes, with a predominant down-regulation.
• The tested A₃R agonist does not induce a classical M2 neuroprotective microglial phenotype under these experimental conditions.
• Further research is needed to elucidate the precise role of A₃R modulation in neuroinflammation and neurodegeneration.